{"id":50443,"date":"2012-07-31T19:24:35","date_gmt":"2012-07-31T19:24:35","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/water-street-closes-750-million-private-equity-fund.php"},"modified":"2012-07-31T19:24:35","modified_gmt":"2012-07-31T19:24:35","slug":"water-street-closes-750-million-private-equity-fund","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/water-street-closes-750-million-private-equity-fund.php","title":{"rendered":"Water Street Closes $750 Million Private Equity Fund"},"content":{"rendered":"<p><p>    CHICAGO, July 31, 2012 \/PRNewswire\/ --Water Street Healthcare Partners, a    strategic private equity firm focused exclusively on the health    care industry, announced today the closing of its third private    equity fund, Water Street Healthcare Partners III, L.P. (\"Fund    III\"). The fund closed at its cap of $750 million of investor    commitments, exceeding the original target of $650 million when    fundraising began in early June. Investors in the fund    include leading domestic and international pension funds,    endowments and financial institutions, most of which have    invested in Water Street since the firm raised its first fund    in 2006.  <\/p>\n<p>    \"We are very pleased with the value Water Street has built in    its group of health care companies, and the strong results its    team has achieved over the past six years,\" said Investment    Director Brian Welker, Allianz Capital Partners, an investor in    Water Street since 2006. \"What we appreciate most about Water    Street is how it engages its entire team in the value creation    process. It leverages the vast experience of its    operating partners with the financial expertise of its    investment partners to proactively source and invest in    attractive companies, strategically expand their products and    services, and build them into market leaders.\"  <\/p>\n<p>    Water Street has completed more than 30 strategic acquisitions    and mergers, the majority of which were privately negotiated,    to build 16 market-leading health care companies in six years.    The firm has acquired and grown its companies through    partnerships with the world's premier health care corporations    including Johnson & Johnson, Medtronic, Inc. and Gentiva    Health Services, Inc., as well as founders and executives of    middle-market companies. In the past three months, Water    Street acquired Breg, Inc. from Orthofix International,    N.V., divested its dental pharmaceutical company, OraPharma, to Valeant Pharmaceuticals    International, Inc., and divested Physiotherapy Associates after building    into a national outpatient rehabilitation services leader.  <\/p>\n<p>    \"We are deeply grateful to our investors for their overwhelming    support of Water Street. Their recognition of the results    our team has achieved and enthusiasm for our strategy enabled    us to raise this fund efficiently. Importantly, by    extending our partnership, investors continue to support our    strategy of building market-leading companies of greater    long-term value in targeted growth segments of health    care. We will continue to invest our team's deep health    care expertise, extensive operating experience and network of    industry relationships to create transformational growth for    our companies and deliver outstanding results for our    investors,\" said Tim Dugan, managing partner, Water Street.  <\/p>\n<p>    With Fund III, Water Street's total capital under management    increases to nearly $2 billion. Water Street will    continue to pursue proprietary investments in four segments of    health care: medical and diagnostic products and    devices, specialty distribution, outsourced health care services, and    specialty pharmaceutical products and    services. Target investments range in size from $50    million to $500 million in value. Water Street will    continue to grow its companies through a combination of    strategic acquisitions and organic initiatives.  <\/p>\n<p>    Water Street closed its inaugural equity fund of $370 million    in 2006 and its second equity fund of $650 million in    2008.  <\/p>\n<p>    About Water Street  <\/p>\n<p>    Water Street is a strategic private equity    firm focused exclusively on health care. The firm has a strong    record of building market-leading companies across key growth sectors in health care. It has worked with    some of the world's leading health care companies on its    investments including Gentiva, Johnson & Johnson, Medtronic    and Smith & Nephew. Water Street's team is comprised of    industry executives and private equity professionals with decades    of experience investing in and operating global health care    businesses. The firm is headquartered in Chicago. For more    information about Water Street, visit waterstreet.com.  <\/p>\n<\/p>\n<p>See the original post here: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/water-street-closes-750-million-120100087.html;_ylt=A2KJNF_ZMBhQbGEAGTf_wgt.\" title=\"Water Street Closes $750 Million Private Equity Fund\">Water Street Closes $750 Million Private Equity Fund<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> CHICAGO, July 31, 2012 \/PRNewswire\/ --Water Street Healthcare Partners, a strategic private equity firm focused exclusively on the health care industry, announced today the closing of its third private equity fund, Water Street Healthcare Partners III, L.P. (\"Fund III\").  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/water-street-closes-750-million-private-equity-fund.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-50443","post","type-post","status-publish","format-standard","hentry","category-health-care"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/50443"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=50443"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/50443\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=50443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=50443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=50443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}